ReviewApplied biochemistry and biotechnology2026
Superfolder Green Fluorescent Protein (sfGFP): A Versatile Tool for Biotechnology Research.
Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Superfolder green fluorescent protein (sfGFP) is an engineered GFP variant best known for its robust folding, reliable chromophore maturation, and high tolerance to fusion partners. This review argues that the principal value of sfGFP lies not in universal superiority in brightness or photostability, but in its ability to preserve fluorescence under conditions that compromise the folding or performance of conventional GFP variants. These contexts include difficult fusion proteins, split-fragment complementation systems, circularly permuted biosensor scaffolds, recombinant expression platforms, and secretion-associated workflows. Because sfGFP is directly encoded by a DNA sequence, it can be expressed in living cells as a fusion tag and generate fluorescence through autocatalytic chromophore maturation without requiring exogenous cofactors or synthetic fluorophores, enabling live-cell localization, protein detection, and dynamic biosensing. Its high solubility and folding robustness can also improve soluble recovery, reduce aggregation, and facilitate the purification of recombinant fusion proteins. However, sfGFP is not without limitations: its fluorescence remains pH-sensitive, its monomeric behavior can be context-dependent, and its photostability is not optimized for prolonged high-intensity illumination. Therefore, sfGFP should be selected according to application-specific requirements and benchmarked against newer green fluorescent proteins in terms of folding robustness, brightness, maturation kinetics, monomericity, pH tolerance, and photostability. Future integration of sfGFP with cell-free systems, synthetic biology, and protein-design strategies is likely to further establish it as a robust fluorescent scaffold for biotechnology.
Indexed as
Identifiers
42307699What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.